.jpg | CAS_number = 33419-42-0 | ATC_prefix = L01 | ATC_suffix = CB01 | ATC_supplemental = | PubChem = 36462 | DrugBank = APRD00239 | chemical_formula = C29H32O13 | molecular_weight = 588.557 g/mol | bioavailability = | protein_bound = 97% | metabolism = | elimination_half-life = oral: 6 h., iv: 6-12 h., iv in children: 3 h. | pregnancy_category = | legal_status = | routes_of_administration = Oral, intravenous | excretion = Renal and faeces }} Etoposide phosphate (Eposin®, Etopophos®, Vepesid®, VP-16®) is an inhibitor of the enzyme topoisomerase II. It is used as a form of chemotherapy for malignancies such as lung cancer, testicular cancer, lymphoma, non-lymphocytic leukemia, and glioblastoma multiforme. It is often given in combination with other drugs.
Chemically it derives from podophyllotoxin, a toxin found in the American Mayapple.
It is given intravenously or by mouth in capsule form. If the drug is given by IV it must be done slowly over a 30 to 60 minute period because it can lower blood pressure as it is being administered. Blood pressure is checked often during infusing. The physician may lengthen or shorten the time depending on circumstances.
Less common are:
It is advised to drink lots of fluids after treatment to prevent damage to the bladder and kidneys, typically 1.5 to 3.5 litres of water on the day of treatment and for several days after.
This article is licensed under the GNU Free Documentation License.
It uses material from the
"Etoposide".
Home Page • arts • business • computers • games • health • hospitals • home • kids & teens • news • physicians • recreation• reference • regional • science • shopping • society • sports • world